Yusuke Nakamura to Enzyme Inhibitors
This is a "connection" page, showing publications Yusuke Nakamura has written about Enzyme Inhibitors.
Connection Strength
0.166
-
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82.
Score: 0.088
-
Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839. Int J Oncol. 2003 Jul; 23(1):29-39.
Score: 0.040
-
The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck. Oral Oncol. 2018 06; 81:100-108.
Score: 0.028
-
Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis. Mol Cell Biol. 2002 Dec; 22(24):8695-708.
Score: 0.010